Arrowhead Pharmaceuticals, Inc. today announced the pricing of its concurrent public offerings of (i) $625,000,000 aggregate principal amount of 0.00% convertible senior notes due 2032 (the "notes") ...

Arrowhead Pharmaceuticals, Inc. today announced its intention to offer, subject to market and other conditions, $500 million aggregate principal amount of convertible senior notes due 2032 (the "notes ...

Axon Enterprise ( (AXON)) just unveiled an update. On December 18, 2025, Axon Enterprise, Inc. announced that it had delivered a notice of redemption for its 0.50% convertible senior notes due 2027, ...

The latest update is out from ETHZilla Corporation ( (ETHZ)). On December 16, 2025, ETHZilla Corporation held a special meeting where stockholders representing 79.8% of voting shares were present. The ...

AUSTIN, Texas and NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) ( “T1,” “T1 Energy” or the “Company”) today announced the pricing of its previously announced underwritten ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into separate, privately negotiated exchange agreements with a ...

AUSTIN, Texas, Dec. 10, 2025 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) today announced proposed underwritten public offerings of $120.0 million aggregate ...

CHICAGO--(BUSINESS WIRE)--Exelon Corporation (Nasdaq: EXC) today announced that it intends to offer, subject to market and other conditions, $900 million aggregate principal amount of its convertible ...

VANCOUVER, BC AND BREDA, NETHERLANDS / ACCESS Newswire / November 17, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTCQX:OGOFF)(FSE:OGF0) (“Organto” or the “Company”), is pleased to announce that it has ...

In particular, and without limitation, this news release contains forward-looking statements respecting the completion of the prepayment of the Convertible notes and accrued interest; Organto’s belief ...